Valeur; Eric

Patent Applications and Registrations

Patent applications and USPTO patent grants for Valeur; Eric.The latest application filed is for "glp-1 receptor ligand moiety conjugated oligonucleotides and uses thereof".

Company Profile

5.19.17

Valeur; Eric - Molndal SE
Valeur; Eric - Vieux-Ferrette FR
Valeur; Eric - Bretigny sur Orge FR
- Vieux-Ferrette FR
Valeur; Eric - Hundsbach FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses Thereof App 20210346509 - Monia; Brett P. ; et al.	2021-11-11
Glp-1 Receptor Ligand Moiety Conjugated Oligonucleotides And Uses Thereof App 20200268898 - MONIA; Brett P. ; et al.	2020-08-27
Therapeutic agents Grant 10,414,726 - Golding , et al. Sept	2019-09-17
GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses Thereof App 20190134214 - Monia; Brett P. ; et al.	2019-05-09
Therapeutic Agents App 20180118684 - GOLDING; Bernard Thomas ; et al.	2018-05-03
Therapeutic Agents App 20160355478 - GOLDING; Bernard Thomas ; et al.	2016-12-08
Complement pathway modulators and uses thereof Grant 9,452,990 - Dechantsreiter , et al. September 27, 2	2016-09-27
Therapeutic agents Grant 9,358,222 - Golding , et al. June 7, 2	2016-06-07
Method of stimulating insulin secretion and/or modulating INS-1 kinase with substituted pyrazinones and/or substituted tetrahydroquinoxalinones Grant 9,233,937 - Botton , et al. January 12, 2	2016-01-12
Complement Pathway Modulators and Uses Thereof App 20150126492 - Dechantsreiter; Michael ; et al.	2015-05-07
Arylpyrazinones Such As But Not Limited To 3-(4-chlorophenyl-1-ethylpyrazin-2-(1h0)-one App 20140329837 - BOTTON; Gerard ; et al.	2014-11-06
Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes Grant 8,835,634 - unknownunknownBotton , et al. September 16, 2	2014-09-16
Substituted pyrazin-2-ones and substituted 5,6,7,8-tetrahydroquinoxalin-2-ones and methods of use thereof Grant 8,815,859 - Botton , et al. August 26, 2	2014-08-26
Therapeutic Agents App 20140194486 - GOLDING; Bernard Thomas ; et al.	2014-07-10
Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes Grant 8,642,617 - Botton , et al. February 4, 2	2014-02-04
Therapeutic agents Grant 08618158 -	2013-12-31
Therapeutic agents Grant 8,618,158 - Golding , et al. December 31, 2	2013-12-31
Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes Grant 8,609,689 - Botton , et al. December 17, 2	2013-12-17
Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors Grant 8,486,964 - Valeur , et al. July 16, 2	2013-07-16
Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes App 20130123257 - BOTTON; Gerard ; et al.	2013-05-16
Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes Grant 8,415,352 - Botton , et al. April 9, 2	2013-04-09
Pyridopyrazinones Derivatives Insulin Secretion Stimulators, Methods For Obtaining Them And Use Thereof For The Treatment Of Diabetes App 20130023537 - BOTTON; Gerard ; et al.	2013-01-24
Pyridopyrazinones Derivatives Insulin Secretion Stimulators, Methods For Obtaining Them And Use Thereof For The Treatment Of Diabetes App 20120122876 - Botton; Gerard ; et al.	2012-05-17
Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes Grant 8,178,556 - Botton , et al. May 15, 2	2012-05-15
New Therapeutic Agents App 20110224274 - Golding; Bernard Thomas ; et al.	2011-09-15
Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors App 20110172265 - Valeur; Eric ; et al.	2011-07-14
Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes App 20110046159 - Botton; Gerard ; et al.	2011-02-24
Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes App 20110015194 - Botton; Gerard ; et al.	2011-01-20
Pyridopyrazinones Derivatives Insulin Secretion Stimulators, Methods For Obtaining Them And Use Thereof For The Treatment Of Diabetes App 20110009417 - Botton; Gerard ; et al.	2011-01-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.